Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
64
Views
11
CrossRef citations to date
0
Altmetric
Original Research

High expression of CIP2A protein is associated with tumor aggressiveness in stage I–III NSCLC and correlates with poor prognosis

Geqi Cha1 Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
,
Jianyu Xu1 Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
,
Xiangying Xu1 Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, HeilongjiangCorrespondence[email protected]
,
Bin Li2 Department of Plastic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong
,
Shan Lu1 Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
,
Abiyasi Nanding3 Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
,
Songliu Hu1 Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
&
Shilong Liu1 Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
 show all
Pages 5907-5914 | Published online: 12 Dec 2017

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Shihua Zhang & Kejian Wang. (2020) miR-383 Down-Regulates the Oncogene CIP2A to Influence Glioma Proliferation and Invasion. OncoTargets and Therapy 13, pages 4063-4074.
Read now
Bharath Kumar Velmurugan, Hsin-Kai Wang, Chia-Min Chung, Chien-Hsun Lee, Lan-Ru Huang, Kun-Tu Yeh & Shu-Hui Lin. (2019) CIP2A overexpression in Taiwanese oral cancer patients. Cancer Management and Research 11, pages 2589-2594.
Read now

Articles from other publishers (9)

Danyang Chen, Siwen Fan, Jun Wang, Yanqing Liang, Pan Li, Xinwu Lv, Yanqin Sun, Qian Wang, Hao Liu, Chuantao Zhang & Yanmei Yi. (2023) Cip2a induces arginine biosynthesis and promotes tumor progression in non‐small cell lung cancer. Molecular Carcinogenesis 62:4, pages 561-572.
Crossref
Beibei Chen, Huihui Hu & Xiaobing Chen. (2023) From Basic Science to Clinical Practice: The Role of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A)/p90 in Cancer. Frontiers in Genetics 14.
Crossref
Fanggui Shao, Liqun Ling, Changhong Li, Xiaolu Huang, Yincai Ye, Meijuan Zhang, Kate Huang, Jingye Pan, Jie Chen & Yumin Wang. (2022) Establishing a metastasis-related diagnosis and prognosis model for lung adenocarcinoma through CRISPR library and TCGA database. Journal of Cancer Research and Clinical Oncology 149:2, pages 885-899.
Crossref
Hisham Saafan, Ahmad Alahdab, Robin Michelet, Linus Gohlke, Janine Ziemann, Stefan Holdenrieder, Katie-May McLaughlin, Mark N. Wass, Jindrich CinatlJr.Jr., Martin Michaelis, Charlotte Kloft & Christoph A Ritter. (2021) Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell Line. Cells 10:4, pages 716.
Crossref
Nicharat Sriratanasak, Korrakod Petsri, Apirat Laobuthee, Worawat Wattanathana, Chanida Vinayanuwattikun, Sudjit Luanpitpong & Pithi Chanvorachote. (2020) Novel c-Myc–Targeting Compound N , N -Bis (5-Ethyl-2-Hydroxybenzyl) Methylamine for Mediated c-Myc Ubiquitin-Proteasomal Degradation in Lung Cancer Cells . Molecular Pharmacology 98:2, pages 130-142.
Crossref
James A. Austin, Rosalind E. JenkinsGemma M. AustinMark A. GlennKaren DunnLaura ScottClaire M. LucasRichard E. Clark. (2019) Cancerous inhibitor of protein phosphatase 2A (CIP2A) modifies energy metabolism via 5′ AMP-activated protein kinase signalling in malignant cells. Biochemical Journal 476:15, pages 2255-2269.
Crossref
Pengfei Liu, Yuchen Xiang, Xuewen Liu, Te Zhang, Rui Yang, Sen Chen, Li Xu, Qingqing Yu, Huzi Zhao, Liang Zhang, Ying Liu & Yuan Si. (2019) Cucurbitacin B Induces the Lysosomal Degradation of EGFR and Suppresses the CIP2A/PP2A/Akt Signaling Axis in Gefitinib-Resistant Non-Small Cell Lung Cancer. Molecules 24:3, pages 647.
Crossref
Sahar Mazhar, Sarah E. Taylor, Jaya Sangodkar & Goutham Narla. (2019) Targeting PP2A in cancer: Combination therapies. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1866:1, pages 51-63.
Crossref
Lin Lin & Yong Wang. (2018) miR-548b-3p Regulates Proliferation, Apoptosis, and Mitochondrial Function by Targeting CIP2A in Hepatocellular Carcinoma. BioMed Research International 2018, pages 1-9.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.